Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

aTYR PHARMA INC (ATYR) AI Dilution Summary

Updated Aug 31, 2026

aTyr Pharma has 98,087,425 shares of common stock outstanding on the 2026-08-31 split basis. The identified potential new shares from live instruments total 14,014,534, equal to 14.3% of shares outstanding, and that total is composed entirely of equity-plan awards outstanding — stock options, restricted stock units and employee stock purchase plan rights held by employees, officers and directors as compensation.